A share price of Ideaya Biosciences Inc [IDYA] is currently trading at $27.69, down -2.43%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IDYA shares have gain 3.36% over the last week, with a monthly amount glided 13.30%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ideaya Biosciences Inc [NASDAQ: IDYA] stock has seen the most recent analyst activity on September 18, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $50. Previously, Citizens JMP started tracking the stock with Mkt Outperform rating on September 04, 2025, and set its price target to $41. On September 04, 2025, Barclays initiated with a Overweight rating and assigned a price target of $40 on the stock. TD Cowen started tracking the stock assigning a Buy rating. Wells Fargo started tracking with a Overweight rating for this stock on June 26, 2025, and assigned it a price target of $44. In a note dated November 18, 2024, Stephens initiated an Overweight rating and provided a target price of $51 on this stock.
Ideaya Biosciences Inc experienced fluctuations in its stock price throughout the past year between $13.45 and $32.67. Currently, Wall Street analysts expect the stock to reach $41 within the next 12 months. Ideaya Biosciences Inc [NASDAQ: IDYA] shares were valued at $27.69 at the most recent close of the market. An investor can expect a potential return of 48.07% based on the average IDYA price forecast.
Analyzing the IDYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -54.89%, Pretax Profit Margin comes in at -47.29%, and Net Profit Margin reading is -47.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.31 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.84 points at the first support level, and at 26.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.98, and for the 2nd resistance point, it is at 30.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ideaya Biosciences Inc [NASDAQ:IDYA] is 12.39. As well, the Quick Ratio is 12.39, while the Cash Ratio is 2.07. Considering the valuation of this stock, the price to sales ratio is 346.69, the price to book ratio is 2.53.
